UK government snubs GSK in favour of rival RSV shot from Pfizer
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
Citi estimates Zantac settlement costs at US$3 billionGSK shares plunged in the wake of a court ruling that the UK ...
GSK alleges Pfizer infringed four of its patents in developing a competing RSV vaccine AFP GlaxoSmithKline sued Pfizer on Wednesday ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures